08:00 , Nov 13, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes; obesity Ceramide synthase 6 (CERS6; LASS6) In vitro and mouse studies suggest inhibiting CERS6 could help treat obesity and diabetes. In hepatocytes from...